Specifically, Cisd2 haploinsufficiency, namely one copy of Cisd2 in the liver, is insufficient and this accelerates the pathogenesis of NAFLD and exacerbates progression toward NASH. Here, CISD2 is linked to metabolic dysfunction-associated steatotic liver disease.